The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells

Enhancer of zeste homolog 2 (EZH2) is the catalytic unit of polycomb repressive complex 2 (PRC2) which epigenetically silences many genes involved in tumor-suppressive mechanisms via the trimethylation of lysine 27 of histone H3 (H3K27me3). We recently found that overexpression of EZH2 was associate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Principais autores: Yu, Tianfu, Wang, Yingyi, Hu, Qi, Wu, WeiNing, Wu, Youzhi, Wei, Wenjin, Han, Dongfeng, You, Yongping, Lin, Ning, Liu, Ning
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716734/
https://ncbi.nlm.nih.gov/pubmed/29228694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21311
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados